{"formats":[{"name":"JSON","format":"json","url":"\/downloads\/2025\/code-json\/38.2-1334.14.json"},{"name":"Plain Text","format":"text","url":"\/downloads\/2025\/code-text\/38.2-1334.14.txt"},{"name":"XML","format":"xml","url":"\/downloads\/2025\/code-xml\/38.2-1334.14.xml"},{"name":"HTML","format":"html","url":"\/downloads\/2025\/code-html\/38.2-1334.14.html"}],"law_id":66192,"edition_id":1,"section_id":66192,"structure_id":13689,"section_number":"38.2-1334.14","catch_line":"Confidentiality","history":"2017, c. 643.","full_text":"A\n\nThe CGAD is recognized by the Commonwealth as containing confidential and sensitive information related to an insurer or insurance group’s internal operations. This information includes proprietary and trade secret information that has the potential for harm and competitive disadvantage to the insurer or insurance group if the information is made public. The CGAD shall be a confidential document filed with the Commission, the CGAD may be shared only as stated in this article and to assist the Commission in the performance of its duties, and in no event shall the CGAD be subject to public disclosure.B\n\nDocuments, materials, or other information, including the CGAD, in the possession of or control of the Commission that is obtained by, created by, or disclosed to the Commission or any other person under this article is declared to be proprietary and to contain trade secrets. All such documents, materials, or other information shall be confidential by law and privileged, shall not be subject to subpoena, and shall not be subject to discovery or admissible in evidence in any private civil action. However, the Commission is authorized to use the documents, materials, or other information in the furtherance of any regulatory or legal action brought as a part of the Commission’s official duties. The Commission shall not otherwise make the documents, materials, or other information public without the prior written consent of the insurer. Nothing in this section shall be construed to require written consent of the insurer before the Commission may share or receive confidential documents, materials, or other CGAD-related information pursuant to subsection C to assist in the performance of the Commission’s regular duties.C\n\nNeither the Commission nor any person who received documents, materials, or other CGAD-related information, through examination or otherwise, while acting under the authority of the Commission or with whom such documents, materials, or other information are shared pursuant to this article shall be permitted or required to testify in any private civil action concerning any confidential documents, materials, or information subject to subsection A.D\n\nIn order to assist in the performance of the Commission’s regulatory duties, the Commission:1\n\nMay, upon request, share documents, materials, or other CGAD-related information, including the confidential and privileged documents, materials, or information subject to subsection A, including proprietary and trade secret documents and materials, with other state, federal, and international financial regulatory agencies, including any forum for cooperation and communication between insurance supervisors, known as a supervisory college, that is established for the purpose of facilitating the effectiveness of supervision of insurers, with the NAIC, and with third-party consultants pursuant to § 38.2-1334.15, provided that the recipient agrees in writing to maintain the confidentiality and privileged status of the CGAD-related documents, materials, or other information and has verified in writing the legal authority to maintain confidentiality; and2\n\nMay receive documents, materials, or other CGAD-related information, including otherwise confidential and privileged documents, materials, or information, including proprietary and trade-secret information or documents, from regulatory officials of other foreign or domestic jurisdictions, including members of any supervisory college, and from the NAIC and shall maintain as confidential or privileged any documents, materials, or information received with notice or the understanding that it is confidential or privileged under the laws of the jurisdiction that is the source of the document, material, or information.E\n\nThe sharing of information and documents by the Commission pursuant to this article shall not constitute a delegation of regulatory authority or rulemaking, and the Commission is solely responsible for the administration, execution, and enforcement of the provisions of this article.F\n\nNo waiver of any applicable privilege or claim of confidentiality in the documents, proprietary and trade-secret materials, or other CGAD-related information shall occur as a result of disclosure of such CGAD-related information or documents to the Commission under this section or as a result of sharing as authorized in this article.","order_by":null,"text":{"0":{"id":240439,"text":"The CGAD is recognized by the Commonwealth as containing confidential and sensitive information related to an insurer or insurance group’s internal operations. This information includes proprietary and trade secret information that has the potential for harm and competitive disadvantage to the insurer or insurance group if the information is made public. The CGAD shall be a confidential document filed with the Commission, the CGAD may be shared only as stated in this article and to assist the Commission in the performance of its duties, and in no event shall the CGAD be subject to public disclosure.","type":"section","prefixes":["A"],"prefix":"A","entire_prefix":"A","prefix_anchor":"A","level":1,"next_prefix":"B"},"1":{"id":240440,"text":"Documents, materials, or other information, including the CGAD, in the possession of or control of the Commission that is obtained by, created by, or disclosed to the Commission or any other person under this article is declared to be proprietary and to contain trade secrets. All such documents, materials, or other information shall be confidential by law and privileged, shall not be subject to subpoena, and shall not be subject to discovery or admissible in evidence in any private civil action. However, the Commission is authorized to use the documents, materials, or other information in the furtherance of any regulatory or legal action brought as a part of the Commission’s official duties. The Commission shall not otherwise make the documents, materials, or other information public without the prior written consent of the insurer. Nothing in this section shall be construed to require written consent of the insurer before the Commission may share or receive confidential documents, materials, or other CGAD-related information pursuant to subsection C to assist in the performance of the Commission’s regular duties.","type":"section","prefixes":["B"],"prefix":"B","entire_prefix":"B","prefix_anchor":"B","level":1,"prior_prefix":"A","next_prefix":"C"},"2":{"id":240441,"text":"Neither the Commission nor any person who received documents, materials, or other CGAD-related information, through examination or otherwise, while acting under the authority of the Commission or with whom such documents, materials, or other information are shared pursuant to this article shall be permitted or required to testify in any private civil action concerning any confidential documents, materials, or information subject to subsection A.","type":"section","prefixes":["C"],"prefix":"C","entire_prefix":"C","prefix_anchor":"C","level":1,"prior_prefix":"B","next_prefix":"D"},"3":{"id":240442,"text":"In order to assist in the performance of the Commission’s regulatory duties, the Commission:","type":"section","prefixes":["D"],"prefix":"D","entire_prefix":"D","prefix_anchor":"D","level":1,"prior_prefix":"C","next_prefix":"D1"},"4":{"id":240443,"text":"May, upon request, share documents, materials, or other CGAD-related information, including the confidential and privileged documents, materials, or information subject to subsection A, including proprietary and trade secret documents and materials, with other state, federal, and international financial regulatory agencies, including any forum for cooperation and communication between insurance supervisors, known as a supervisory college, that is established for the purpose of facilitating the effectiveness of supervision of insurers, with the NAIC, and with third-party consultants pursuant to § 38.2-1334.15, provided that the recipient agrees in writing to maintain the confidentiality and privileged status of the CGAD-related documents, materials, or other information and has verified in writing the legal authority to maintain confidentiality; and","type":"section","prefixes":["D","1"],"prefix":"1","entire_prefix":"D1","prefix_anchor":"D1","level":2,"prior_prefix":"D","next_prefix":"D2"},"5":{"id":240444,"text":"May receive documents, materials, or other CGAD-related information, including otherwise confidential and privileged documents, materials, or information, including proprietary and trade-secret information or documents, from regulatory officials of other foreign or domestic jurisdictions, including members of any supervisory college, and from the NAIC and shall maintain as confidential or privileged any documents, materials, or information received with notice or the understanding that it is confidential or privileged under the laws of the jurisdiction that is the source of the document, material, or information.","type":"section","prefixes":["D","2"],"prefix":"2","entire_prefix":"D2","prefix_anchor":"D2","level":2,"prior_prefix":"D1","next_prefix":"E"},"6":{"id":240445,"text":"The sharing of information and documents by the Commission pursuant to this article shall not constitute a delegation of regulatory authority or rulemaking, and the Commission is solely responsible for the administration, execution, and enforcement of the provisions of this article.","type":"section","prefixes":["E"],"prefix":"E","entire_prefix":"E","prefix_anchor":"E","level":1,"prior_prefix":"D2","next_prefix":"F"},"7":{"id":240446,"text":"No waiver of any applicable privilege or claim of confidentiality in the documents, proprietary and trade-secret materials, or other CGAD-related information shall occur as a result of disclosure of such CGAD-related information or documents to the Commission under this section or as a result of sharing as authorized in this article.","type":"section","prefixes":["F"],"prefix":"F","entire_prefix":"F","prefix_anchor":"F","level":1,"prior_prefix":"E"}},"ancestry":[{"id":13689,"edition_id":1,"name":"Corporate Governance Annual Disclosures","identifier":"5.2","label":"article","depth":3,"order_by":1,"parent_id":13289,"metadata":{},"date_created":"2026-06-26 03:45:34","date_modified":"2026-06-26 03:45:34","permalink":{"id":211729,"object_type":"structure","relational_id":13689,"identifier":"5.2","token":"38.2\/13\/5.2","url":"\/38.2\/13\/5.2\/","edition_id":1,"permalink":0,"preferred":1}},{"id":13289,"edition_id":1,"name":"Reports, Reserves and Examinations, Insurance Holding Companies, Reinsurance Intermediaries, and Managing General Agents","identifier":"13","label":"chapter","depth":2,"order_by":1,"parent_id":12698,"metadata":{},"date_created":"2026-06-26 03:44:35","date_modified":"2026-06-26 03:44:35","permalink":{"id":211347,"object_type":"structure","relational_id":13289,"identifier":"13","token":"38.2\/13","url":"\/38.2\/13\/","edition_id":1,"permalink":0,"preferred":1}},{"id":12698,"edition_id":1,"name":"Insurance","identifier":"38.2","label":"title","depth":1,"order_by":1,"parent_id":null,"metadata":{},"date_created":"2026-06-26 03:43:49","date_modified":"2026-06-26 03:43:49","permalink":{"id":210661,"object_type":"structure","relational_id":12698,"identifier":"38.2","token":"38.2","url":"\/38.2\/","edition_id":1,"permalink":0,"preferred":1}}],"structure_contents":[{"id":65917,"structure_id":13689,"section_number":"38.2-1334.11","catch_line":"Definitions","url":"\/38.2-1334.11\/","token":"38.2\/13\/5.2\/38.2-1334.11","metadata":false},{"id":87455,"structure_id":13689,"section_number":"38.2-1334.12","catch_line":"Disclosure requirement","url":"\/38.2-1334.12\/","token":"38.2\/13\/5.2\/38.2-1334.12","metadata":false},{"id":71848,"structure_id":13689,"section_number":"38.2-1334.13","catch_line":"Contents of Corporate Governance Annual Disclosure","url":"\/38.2-1334.13\/","token":"38.2\/13\/5.2\/38.2-1334.13","metadata":false},{"id":66192,"structure_id":13689,"section_number":"38.2-1334.14","catch_line":"Confidentiality","url":"\/38.2-1334.14\/","token":"38.2\/13\/5.2\/38.2-1334.14","metadata":false},{"id":86182,"structure_id":13689,"section_number":"38.2-1334.15","catch_line":"NAIC and third-party consultants","url":"\/38.2-1334.15\/","token":"38.2\/13\/5.2\/38.2-1334.15","metadata":false},{"id":54668,"structure_id":13689,"section_number":"38.2-1334.16","catch_line":"Rules and regulations","url":"\/38.2-1334.16\/","token":"38.2\/13\/5.2\/38.2-1334.16","metadata":false},{"id":74286,"structure_id":13689,"section_number":"38.2-1334.17","catch_line":"Sanctions","url":"\/38.2-1334.17\/","token":"38.2\/13\/5.2\/38.2-1334.17","metadata":false}],"previous_section":{"id":71848,"structure_id":13689,"section_number":"38.2-1334.13","catch_line":"Contents of Corporate Governance Annual Disclosure","url":"\/38.2-1334.13\/","token":"38.2\/13\/5.2\/38.2-1334.13","metadata":false},"next_section":{"id":86182,"structure_id":13689,"section_number":"38.2-1334.15","catch_line":"NAIC and third-party consultants","url":"\/38.2-1334.15\/","token":"38.2\/13\/5.2\/38.2-1334.15","metadata":false},"metadata":false,"official_url":"https:\/\/law.lis.virginia.gov\/vacode\/38.2-1334.14\/","history_text":"

This law was first created in 2017. The record of its establishment is cataloged in chapter 643<\/a> of that year\u2019s edition of \u201cActs of Assembly,\u201d the annual state publication listing all changes made to the Code of Virginia in that year.<\/p>","references":false,"refers_to":[{"id":86182,"section_number":"38.2-1334.15","catch_line":"NAIC and third-party consultants","order_by":null,"url":"\/38.2-1334.15\/"}],"permalink":{"id":211743,"object_type":"law","relational_id":66192,"identifier":"38.2-1334.14","token":"38.2\/13\/5.2\/38.2-1334.14","url":"\/38.2-1334.14\/","edition_id":1,"permalink":0,"preferred":1},"url":"\/38.2-1334.14\/","token":"38.2\/13\/5.2\/38.2-1334.14","dublin_core":{"Title":"Confidentiality","Type":"Text","Format":"text\/html","Identifier":"\u00a7 38.2-1334.14","Relation":"Code of Virginia"},"html":"\n\t\t\t\t\t\t

A.<\/span> The CGAD<\/span> is recognized by the Commonwealth as containing confidential and sensitive information related to an insurer<\/span> or insurance group<\/span>’s internal operations. This information includes proprietary and trade secret information that has the potential for harm and competitive disadvantage to the insurer<\/span> or insurance group<\/span> if the information is made public. The CGAD<\/span> shall be a confidential document filed with the Commission<\/span>, the CGAD<\/span> may be shared only as stated in this article and to assist the Commission<\/span> in the performance of its duties, and in no event shall the CGAD<\/span> be subject to public disclosure. <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

B.<\/span> Documents, materials<\/span>, or other information, including the CGAD<\/span>, in the possession<\/span> of or control of the Commission<\/span> that is obtained by, created by, or disclosed to the Commission<\/span> or any other person<\/span> under this article is declared to be proprietary and to contain trade secrets. All such documents, materials<\/span>, or other information shall be confidential by law<\/span> and privileged, shall not be subject to subpoena<\/span>, and shall not be subject to discovery<\/span> or admissible<\/span> in evidence<\/span> in any private civil action<\/span>. However, the Commission<\/span> is authorized to use the documents, materials<\/span>, or other information in the furtherance of any regulatory or legal action brought as a part of the Commission<\/span>’s official duties. The Commission<\/span> shall not otherwise make the documents, materials<\/span>, or other information public without the prior written consent of the insurer<\/span>. Nothing in this section shall be construed to require written consent of the insurer<\/span> before the Commission<\/span> may share or receive confidential documents, materials<\/span>, or other CGAD<\/span>-related information pursuant to subsection C to assist in the performance of the Commission<\/span>’s regular duties. <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

C.<\/span> Neither the Commission<\/span> nor any person<\/span> who received documents, materials<\/span>, or other CGAD<\/span>-related information, through examination or otherwise, while acting under the authority of the Commission<\/span> or with whom such documents, materials<\/span>, or other information are shared pursuant to this article shall be permitted or required to testify in any private civil action<\/span> concerning any confidential documents, materials<\/span>, or information subject to subsection A. <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

D.<\/span> In order<\/span> to assist in the performance of the Commission<\/span>’s regulatory duties, the Commission<\/span>: <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

1.<\/span> May, upon request, share documents, materials<\/span>, or other CGAD<\/span>-related information, including the confidential and privileged documents, materials<\/span>, or information subject to subsection A, including proprietary and trade secret documents and materials<\/span>, with other state<\/span>, federal, and international financial regulatory agencies, including any forum for cooperation and communication between insurance supervisors, known as a supervisory college, that is established for the purpose of facilitating the effectiveness of supervision of insurers<\/span>, with the NAIC<\/span>, and with third-party<\/span> consultants pursuant to § 38.2-1334.15<\/a>, provided that the recipient agrees in writing to maintain the confidentiality and privileged status of the CGAD<\/span>-related documents, materials<\/span>, or other information and has verified in writing the legal authority to maintain confidentiality; and <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

2.<\/span> May receive documents, materials<\/span>, or other CGAD<\/span>-related information, including otherwise confidential and privileged documents, materials<\/span>, or information, including proprietary and trade-secret information or documents, from regulatory officials of other foreign or domestic jurisdictions<\/span>, including members of any supervisory college, and from the NAIC<\/span> and shall maintain as confidential or privileged any documents, materials<\/span>, or information received with notice or the understanding that it is confidential or privileged under the laws<\/span> of the jurisdiction<\/span> that is the source of the document, material<\/span>, or information. <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

E.<\/span> The sharing of information and documents by the Commission<\/span> pursuant to this article shall not constitute a delegation of regulatory authority or rulemaking, and the Commission<\/span> is solely responsible for the administration, execution, and enforcement of the provisions of this article. <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

F.<\/span> No waiver<\/span> of any applicable privilege<\/span> or claim of confidentiality in the documents, proprietary and trade-secret materials<\/span>, or other CGAD<\/span>-related information shall occur as a result of disclosure of such CGAD<\/span>-related information or documents to the Commission<\/span> under this section or as a result of sharing as authorized in this article. <\/i><\/a><\/p><\/section>","plain_text":" CODE OF VIRGINIA\n\nCONFIDENTIALITY (\u00a7 38.2-1334.14)\n\nA. The CGAD is recognized by the Commonwealth as containing confidential and\nsensitive information related to an insurer or insurance group’s internal\noperations. This information includes proprietary and trade secret information\nthat has the potential for harm and competitive disadvantage to the insurer or\ninsurance group if the information is made public. The CGAD shall be a\nconfidential document filed with the Commission, the CGAD may be shared only as\nstated in this article and to assist the Commission in the performance of its\nduties, and in no event shall the CGAD be subject to public disclosure.\n\nB. Documents, materials, or other information, including the CGAD, in the\npossession of or control of the Commission that is obtained by, created by, or\ndisclosed to the Commission or any other person under this article is declared\nto be proprietary and to contain trade secrets. All such documents, materials,\nor other information shall be confidential by law and privileged, shall not be\nsubject to subpoena, and shall not be subject to discovery or admissible in\nevidence in any private civil action. However, the Commission is authorized to\nuse the documents, materials, or other information in the furtherance of any\nregulatory or legal action brought as a part of the Commission’s official\nduties. The Commission shall not otherwise make the documents, materials, or\nother information public without the prior written consent of the insurer.\nNothing in this section shall be construed to require written consent of the\ninsurer before the Commission may share or receive confidential documents,\nmaterials, or other CGAD-related information pursuant to subsection C to assist\nin the performance of the Commission’s regular duties.\n\nC. Neither the Commission nor any person who received documents, materials, or\nother CGAD-related information, through examination or otherwise, while acting\nunder the authority of the Commission or with whom such documents, materials, or\nother information are shared pursuant to this article shall be permitted or\nrequired to testify in any private civil action concerning any confidential\ndocuments, materials, or information subject to subsection A.\n\nD. In order to assist in the performance of the Commission’s regulatory\nduties, the Commission:\n\n 1. May, upon request, share documents, materials, or other CGAD-related\n information, including the confidential and privileged documents, materials,\n or information subject to subsection A, including proprietary and trade secret\n documents and materials, with other state, federal, and international\n financial regulatory agencies, including any forum for cooperation and\n communication between insurance supervisors, known as a supervisory college,\n that is established for the purpose of facilitating the effectiveness of\n supervision of insurers, with the NAIC, and with third-party consultants\n pursuant to § 38.2-1334.15, provided that the recipient agrees in writing\n to maintain the confidentiality and privileged status of the CGAD-related\n documents, materials, or other information and has verified in writing the\n legal authority to maintain confidentiality; and\n\n 2. May receive documents, materials, or other CGAD-related information,\n including otherwise confidential and privileged documents, materials, or\n information, including proprietary and trade-secret information or documents,\n from regulatory officials of other foreign or domestic jurisdictions,\n including members of any supervisory college, and from the NAIC and shall\n maintain as confidential or privileged any documents, materials, or\n information received with notice or the understanding that it is confidential\n or privileged under the laws of the jurisdiction that is the source of the\n document, material, or information.\n\nE. The sharing of information and documents by the Commission pursuant to this\narticle shall not constitute a delegation of regulatory authority or rulemaking,\nand the Commission is solely responsible for the administration, execution, and\nenforcement of the provisions of this article.\n\nF. No waiver of any applicable privilege or claim of confidentiality in the\ndocuments, proprietary and trade-secret materials, or other CGAD-related\ninformation shall occur as a result of disclosure of such CGAD-related\ninformation or documents to the Commission under this section or as a result of\nsharing as authorized in this article.\n\nHISTORY: 2017, c. 643.","edition":{"id":1,"name":"2025","slug":"2025","date_created":"2026-06-21 22:39:22","date_modified":"2026-06-21 22:39:22","current":1,"order_by":1,"last_import":null}}